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Cytomegalovirus (CMV) is the major cause of perinatal
viral infections. One to two per cent of infants in the
U. S. are congenitally infected; of these about 10% are
or become symptomatic with such sequelae äs deafness and
mental retardation. Such infants excrete CMV in the
urine at birth. Another 5 per cent of infants are
natally infected and begin to excrete virus at age 1-2
months. Natal infection is probably benign (1).
CMV causes latent infection following primary attack, äs
do other herpesviruses. Women are usually asymptomatic
during primary or reactivation infections. Cervical re-
activation of CMV is common during pregnancy. infants
may be infected during maternal primary or reactivation
CMV infections/ but only those infants whose mothers
have primary disease develop significant sequelae (2 ) .
This phenomenon, forms the basis for development of a live
attenuated CMV vaccine. Diagnosis of CMV infection is
made by urine culture, and confirmed by antibody titers.
No treatment is available.
Herpes simplex viruses I and II are important perinatal
pathogens. Type II is more frequent than Type I. Rärely
HSV is placentally transmitted; the usual mode of infec-
tion is by contact of the infant with maternal genitälia.
Infants may be significally infected after both primary
and recurrent maternal genital HSV. About 70% of HSV in-
fected infants are born to women with no Symptoms of
genital HSV at delivery (3 ) . Since genital HSV infections
appear to be increasing (4 ) , it might be expected that
infections of the newborn may also increase.
Newborns with HSV are rarely asymptomatic. About 80% have
vesicular skin lesions that are an important diagnostic
clue. The infection may be localized (skin/ eye/ CNS) or
disseminated. The prognosis is poor/ with death in 50-85%
and sequelae such äs retardation in 90% of survivors (5 ) .
The antiviral drug adenine arabinoside (Ara-A) may be
effective for treatment (5 ) . Prevention of infection of
infants is frequently attempted by cesarian section of
mothers with known genital HSV.
Chlamydia are also sexually transmitted pathogens with
important sequelae for infants. Chlamydia share character-
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istics of both bacteria and viruses. Conjunctivitis due
to chlamydia occurs in about half the infants born to
infected mothers, and ten to fifteen per cent de-
velop chlamydia pneumonia between the ages of 1-3 months
(6) . These babies have cough, intersitial pneumonia,
eosinophilia, hyperglobulinemia and no fever. Recovery
is hastened by erythromycin or sulfa (7) .
Group B Streptococcus (GBS) is the major cause of
bacterial sepsis and meningitis in the neonate. This
organism is also spread sexually among adults. Infants
may develop early (sepsis, pneumonia) or late (localized:
meningitis, cellulitis) infections. Infection: coloniza-
tion ratios are 1:100. Lack of maternally transmitted
type specific antibody in colonized infants accounts for
development of infection (8) . A recent controlled study
has shown that one injection of aqueous penicillin at birth
protects against early GBS infection (9 ) .
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